fbpx
September 18, 2023

Does Anti-Reflux Surgery Cut Esophageal Cancer Risk? Does Anti-Reflux Surgery Cut Esophageal Cancer Risk?

TOPLINE: For patients with Barrett esophagus, anti-reflux surgery may not reduce but rather increase the risk of esophageal cancer compared with anti-reflux medication, a new study […]
September 18, 2023

Recovering From Long COVID: Thankful for the Little Things Recovering From Long COVID: Thankful for the Little Things

Editor’s note: Find the latest long COVID news and guidance in Medscape’s Long COVID Resource Center. Jennifer Henderson’s road to recovery from long COVID has been […]
September 18, 2023

Does Adding Ipilimumab to Nivolumab Improve Cancer Outcomes? Does Adding Ipilimumab to Nivolumab Improve Cancer Outcomes?

TOPLINE: For advanced cancers other than melanoma, adding ipilimumab to nivolumab does not improve survival over nivolumab alone, but it does increase clinical and financial toxicity.  […]
September 18, 2023

Real-World Data Confirm Efficacy of Dupilumab in Severe EoE Real-World Data Confirm Efficacy of Dupilumab in Severe EoE

TOPLINE: Dupilumab provides histologic, endoscopic, and symptomatic improvement in patients with severe, treatment-refractory, fibrostenotic eosinophilic esophagitis (EoE), new research shows. METHODOLOGY: Researchers conducted a retrospective cohort […]
September 18, 2023

Surge in Peds ADHD Med Errors Prompts Call for Prevention Surge in Peds ADHD Med Errors Prompts Call for Prevention

The frequency of medication errors among children who take drugs to treat attention-deficit/hyperactivity disorder (ADHD) reported to US poison control centers increased by nearly 300% over […]
September 18, 2023

Islet+Kidney Transplants Boost Survival in Type 1 Diabetes Islet+Kidney Transplants Boost Survival in Type 1 Diabetes

TOPLINE: Patients with type 1 diabetes who received transplanted islets along with a kidney transplant had significantly reduced mortality and transplant failure risks compared with those […]
September 15, 2023

FDA Approves Momelotinib for Myelofibrosis With Anemia FDA Approves Momelotinib for Myelofibrosis With Anemia

The US Food and Drug Administration (FDA) today approved the JAK inhibitor momelotinib (Ojjaara) for myelofibrosis patients with anemia, according to a press release from maker […]
September 15, 2023

STEMI Trial Fails to Support Post-PCI Anticoagulation STEMI Trial Fails to Support Post-PCI Anticoagulation

The first randomized trial to evaluate postprocedural anticoagulation (PPA) in patients undergoing a primary percutaneous coronary intervention (PCI) for an ST-segment elevation myocardial infarction (STEMI) did […]
September 15, 2023

CHMP Recommends Marketing of Biologic for Atopic Dermatitis CHMP Recommends Marketing of Biologic for Atopic Dermatitis

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization of lebrikizumab for the treatment of adult and […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804805806807808809810811812813814815816817818819820821822823824825826827828829830831832833834835836837838839840841842843844845846847848849850851852853854855856857858859860861862863864865866867868869870871872873874875876877878879880881882883884885886887888889890891892893894895896897898899900901902903904905906907908909910911912913914915916917918919920921922923924925926927928929930931932933934935936937938939940941942943944945946947948949950951952953954955956957958959960961962963964965966967968969970971972973974975976977
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0